Veterinary Medicine Product CAS 7704-67-8 Erythromycin Thiocyanate
![](/ProductImageEN/2024-03-25/6384696069860094326628728.jpg)
Erythromycin thiocyanate is a macrolide antibiotic. It is mainly used as a veterinary drug for the infection of gram-positive bacteria and mycoplasma. It is more used as an initial raw material for the synthesis of erythromycin, roxithromycin, azithromycin, Macrolide antibiotics such as clarithromycin.
Antibacterial spectrum and penicillin similar, and mycoplasma, chlamydia, rickettsia, etc., and Legionella have an antibacterial effect. Suitable for mycoplasma pneumonia, neonatal conjunctivitis caused by Chlamydia trachomatis, infant pneumonia, genitourinary tract infections (including non-gonococcal urethritis), Legionnaires' disease, diphtheria (adjuvant therapy) and diphtheria carriers, skin and soft tissue infections, whooping cough, susceptible strains (Haemophilus influenzae, pneumococcus, hemolytic streptococcus, staphylococcus, etc.) caused by respiratory infections (including pneumonia), Streptococcus angina, Li Side infection, long-term prevention of rheumatic fever and endocarditis prevention , Campylobacter jejuni enteritis, as well as gonorrhea, syphilis, acne and other.
TEST | STANDARD | RESULT |
Appearance | White or almost white crystalline powder | Conform |
Identification | Conform Tests (1) (2) (3) | Positive Reaction |
PH | 6.0-8.0 | 6.6 |
Heavy Metals | ≤20ppm | <20ppm |
Arsenic | ≤2ppm | <2ppm |
Loss on drying | ≤6.0% | 4.2% |
Residue on ignition | ≤1.0% | 0.1% |
Assay | ≥750μ/mg | 780μ/mg |
![](/ProductImageEN/2024-03-25/6384696077201261668002248.jpg)